Uveitis and Ocular Inflammation covers inflammatory conditions affecting the uveal tract and other ocular structures. The session considers infectious and non-infectious mechanisms, autoimmune associations, diagnostic challenges, multimodal imaging, immunomodulatory treatment, biologic therapies, complications, and long-term management of inflammatory eye disease.
Abstract Scope and Participation
Abstracts may address inflammatory mechanisms, clinical presentation, diagnosis, imaging, systemic associations, therapeutic strategies, immunosuppression, biologics, treatment outcomes, and complications. Ophthalmologists, uveitis specialists, immunologists, rheumatologists, researchers, and multidisciplinary clinicians involved in inflammatory diseases are welcome.
Background: Uveitis pattern varies according to regional, demographic, and racial factors. Therefore, an epidemiological study of the distribution of uveitis in various regions in India is likely to…
Aims: This comprehensive review aims to evaluate the mechanism, long-term safety, efficacy, and disease-specific applications of tumour necrosis factor-alpha (TNF-α) inhibitors in the treatment of…
Background: IgG4-Related Disease (IgG4-RD) is a chronic, immune-mediated fibroinflammatory condition recognized as a multisystem disorder, often presenting with organomegaly, fibrosis, and organ…
Introduction: Vogt-Koyanagi-Harada (VKH) disease is rarely observed in preschool-aged children, and when it does occur, it typically presents with exudative retinal detachment during the acute phase.…
We describe the first reported case of granulomatosis polyangiitis (GPA)-associated sclerokeratitis in a patient with treated ocular adnexal lymphoma (OAL). The patient presented with pain and…
We describe the first reported case of granulomatosis polyangiitis (GPA)-associated sclerokeratitis in a patient with treated ocular adnexal lymphoma (OAL). The patient presented with pain and…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Uveitis and Ocular Inflammation work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Uveitis and Ocular Inflammation research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Uveitis and Ocular Inflammation track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Uveitis and Ocular Inflammation. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Uveitis and Ocular Inflammation are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Uveitis and Ocular Inflammation track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
